SAMD13 as a Novel Prognostic Biomarker and its Correlation with Infiltrating Immune Cells in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SAMD13 as a Novel Prognostic Biomarker and its Correlation with Infiltrating Immune Cells in Hepatocellular Carcinoma

Published:2022-12-31 Issue:4 Volume:28 Page:260-275
ISSN:2288-7415
Container-title:Biomedical Science Letters
language:en
Short-container-title:Biomed Sci Letters

Author:

Kim Hye-Ran¹,Seo Choong Won¹,Lee Jae-Ho²,Han Sang Jun³,Kim Jongwan¹

Affiliation:

1. Department of Biomedical Laboratory Science, Dong-Eui Institute of Technology, Busan 47230, Korea

2. Department of Anatomy, Keimyung University School of Medicine, Daegu 42601, Korea

3. Department of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan 48513, Korea

Funder

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Publisher

The Korean Society for Biomedical Laboratory Sciences

Subject

General Medicine

Link

http://pdf.medrang.co.kr/BSL/2022/028/BSL028-04-260.pdf

Reference34 articles.

1. OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma

2. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

5. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of CDC42 effector protein 2 as a novel prognostic biomarker in liver hepatocellular carcinoma: a comprehensive data analysis;Osong Public Health and Research Perspectives;2023-12-31

2. Value of TMEM115 as a Potential Prognostic Biomarker in Liver Hepatocellular Carcinoma;Keimyung Medical Journal;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3